Cite
HARVARD Citation
Forker, L. et al. (n.d.). The hypoxia marker CA-IX is prognostic in soft tissue sarcoma patients treated in the UK phase III VORTEX trial. European journal of cancer. pp. S70-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Forker, L. et al. (n.d.). The hypoxia marker CA-IX is prognostic in soft tissue sarcoma patients treated in the UK phase III VORTEX trial. European journal of cancer. pp. S70-. [Online].